Baricitinib for pseudogout pain and swelling
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests whether the drug baricitinib can help people with pseudogout (a type of arthritis caused by calcium crystals) by reducing joint pain and swelling. It is for people with either hand/wrist joint problems or frequent large joint swelling, and involves a biopsy of the knee or wrist.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 55 years old.
- You must have a confirmed diagnosis of CPPD (pseudogout) based on specific medical criteria.
- You must be willing to have a biopsy of your knee or wrist for the study.
- Your joint symptoms must match one of two patterns: mostly small joints of hands/wrists, or frequent large joint flares.
- You must not have had cancer in the last 5 years, serious infections, or certain blood or organ test abnormalities.
- You must not be taking certain immune-suppressing medicines and must meet safety criteria for the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called tocilizumab can reduce joint pain and swelling in people with chronic CPPD (calcium pyrophosphate deposition disease), a type of arthritis. It is for those who have not gotten enough relief from standard treatments.
This study looks at calcium pyrophosphate deposition (CPPD) disease, a condition where crystals build up in joints and cause pain and swelling. It aims to learn more about how the disease acts in both sudden attacks and long-term joint problems, which could help improve treatment.
This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.
This trial tests whether baricitinib, a pill that lowers inflammation, can also help reduce blood-clotting risk in people with rheumatoid arthritis. It may help if your arthritis is still active despite current treatment, and you have no other major health conditions.
This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.
This Phase 4 study tests whether a JAK inhibitor (baricitinib) can improve how RA-related bone erosion heals. You might be eligible if you have rheumatoid arthritis that is still active despite methotrexate treatment, and you meet the specific safety and medication history rules.
Hear when a new Calcium Pyrophosphate Deposition Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.